Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Outline of Final Research Achievements |
In this study, the chemopreventive effects of therapeutic agents for lifestyle disease or phytochemicals, and its underlying molecular mechanisms were investigated using obesity- and lifestyle disease-related colon cancer models. Metformin, an agent for diabetes, and green tea catechin decreased the number of intestinal tumors in diabetic db/db-Min/+ mice. Besides, astaxanthin, one of phytochemicals, and captopril, an antihypertensive agent, suppressed colonic precancerous lesions in different models. In addition, metformin and astaxanthin prevented the development of liver tumors in obese diabetic mice through the improvement of oxidative stress and chronic inflammation. Thus, these results suggest that certain phytochemicals or therapeutic agents for lifestyle disease may become effective candidates for the chemoprevention of colon carcinogenesis. Clinical trials testing the efficacy of those agents in obese diabetic individuals will be ready to start in our facility.
|